Ameriprise’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Buy
4,746,330
+290,570
+7% +$739K ﹤0.01% 1814
2026
Q1
$8.73M Buy
4,455,760
+1,183,329
+36% +$2.78M ﹤0.01% 2023
2025
Q4
$8.87M Sell
3,272,431
-612,728
-16% -$2.01M ﹤0.01% 2008
2025
Q3
$16.4M Sell
3,885,159
-934,346
-19% -$4.11M ﹤0.01% 1542
2025
Q2
$24M Buy
4,819,505
+184,734
+4% +$802K 0.01% 1242
2025
Q1
$20.4M Sell
4,634,771
-172,095
-4% -$808K 0.01% 1298
2024
Q4
$22.4M Sell
4,806,866
-275,101
-5% -$1.51M 0.01% 1259
2024
Q3
$35.3M Sell
5,081,967
-100,573
-2% -$789K 0.01% 1020
2024
Q2
$40.4M Sell
5,182,540
-2,255,460
-30% -$16.7M 0.01% 905
2024
Q1
$52.8M Buy
7,438,000
+436,497
+6% +$2.89M 0.01% 779
2023
Q4
$46.9M Buy
7,001,503
+4,370,276
+166% +$24.6M 0.01% 805
2023
Q3
$14.8M Buy
2,631,227
+2,160,541
+459% +$14.4M ﹤0.01% 1419
2023
Q2
$2.6M Buy
+470,686
New +$2.53M ﹤0.01% 2746
2020
Q4
Sell
-13,642
Closed -$979K 3785
2020
Q3
$979K Buy
+13,642
New +$722K ﹤0.01% 2978

Other funds holding GDRX

Ameriprise's GDRX Position: Q2 2026 in Review

Ameriprise increased its GoodRx Holdings (GDRX) stake by 6.5% in Q2 2026, buying an estimated $739K and bringing the position to 4,746,330 shares worth $13.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Ameriprise first reported a position in GDRX in Q3 2020 and has held it in 14 quarters since. The position peaked at $52.8M in Q1 2024. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Ameriprise held 4,746,330 shares of GoodRx Holdings worth $13.7M as of Q2 2026.
  • Ameriprise bought 290,570 GoodRx Holdings shares in Q2 2026, an estimated $739K.
  • GoodRx Holdings made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1814 holding.
  • Ameriprise first reported a position in GoodRx Holdings in Q3 2020 and has held it in 14 quarters since.
  • Ameriprise's GoodRx Holdings position peaked at $52.8M in Q1 2024.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.